Human influenza virus infection and apoptosis induction in human vascular endothelial cells.
Acute encephalopathy accompanying influenza virus infection results in brain and systemic organ failure mainly through vasogenic edema with high levels of inflammatory cytokines, such as blood tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, as well as the cytochrome c apoptosis marker. A highly virulent strain of avian influenza virus causes fatal infection in chickens by infecting vascular endothelial cells in systemic organs, inducing apoptosis therein. To verify the possibility of apoptosis induction by human influenza virus in infected human vascular endothelial cells, purified influenza virus-infected human umbilical vein endothelial cells (HUVECs) were examined using a tissue culture method. When pre-treated with TNF-alpha, influenza virus (Philippine strain, H3N2) promoted TNF-alpha induced apoptosis of HUVECs. Viral replication was confirmed in HUVECs infected with the Philippine strain in the absence of TNF-alpha by measurement of the amount of infective virus in the culture supernatant using the tissue culture infectious dose (TCID) method, immunohistochemistry and real-time PCR. The number of influenza virus genomes in the infected HUVECs at 24 hr post-infection increased about fivefold compared to that just after virus adsorption. Many TUNEL-positive influenza virus-infected HUVECs were observed using the TUNEL method. Furthermore, cleaved caspase 3 was also detected in influenza virus-infected cells by immunofluorescence staining. These results demonstrated that human influenza virus can infect and replicate in human vascular endothelial cells and induce apoptosis therein.
Sumikoshi
Makoto
M
Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan.
Hashimoto
Koichi
K
Kawasaki
Yukihiko
Y
Sakuma
Hiroko
H
Suzutani
Tatsuo
T
Suzuki
Hitoshi
H
Hosoya
Mitsuaki
M
D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3 / Q000235:genetics / Q000378:metabolism; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000187:drug effects / Q000201:enzymology / Q000473:pathology* / Q000821:virology*; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D020287:In Situ Nick-End Labeling; D053122:Influenza A Virus, H3N2 Subtype / Q000472:pathogenicity*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014779:Virus Replication
D014409:Tumor Necrosis Factor-alpha; D053148:Caspase 3